MRÁZ, Marek, Dáša DOLEŽALOVÁ, Karla PLEVOVÁ, Kateřina STAŇO KOZUBÍK, Veronika MAYEROVÁ, Kateřina ČERNÁ, Kateřina MUSILOVÁ, Boris TICHÝ, Šárka PAVLOVÁ, Marek BORSKÝ, Jan VERNER, Michael DOUBEK, Yvona BRYCHTOVÁ, Martin TRBUŠEK, Aleš HAMPL, Jiří MAYER and Šárka POSPÍŠILOVÁ. MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood. WASHINGTON: Amer Soc Hematology, 2012, vol. 119, No 9, p. 2110-2113. ISSN 0006-4971. Available from: https://dx.doi.org/10.1182/blood-2011-11-394874.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia
Authors MRÁZ, Marek (203 Czech Republic, guarantor, belonging to the institution), Dáša DOLEŽALOVÁ (203 Czech Republic, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Kateřina STAŇO KOZUBÍK (203 Czech Republic, belonging to the institution), Veronika MAYEROVÁ (203 Czech Republic, belonging to the institution), Kateřina ČERNÁ (203 Czech Republic, belonging to the institution), Kateřina MUSILOVÁ (203 Czech Republic, belonging to the institution), Boris TICHÝ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Marek BORSKÝ (203 Czech Republic, belonging to the institution), Jan VERNER (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Martin TRBUŠEK (203 Czech Republic, belonging to the institution), Aleš HAMPL (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution).
Edition Blood, WASHINGTON, Amer Soc Hematology, 2012, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 9.060
RIV identification code RIV/00216224:14740/12:00059794
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1182/blood-2011-11-394874
UT WoS 000300949500022
Keywords in English CLL PATIENTS; SURVIVAL; SUBTYPES
Tags ok, rivok
Tags International impact
Changed by Changed by: Olga Křížová, učo 56639. Changed: 11/4/2013 13:02.
Abstract
MicroRNAs (miRNAs) play a key role in chronic lymphocytic leukemia as well as in normal B cells. Notably, miRNA gene encoding miR-650 and its homologs overlap with several variable (V) subgenes coding for lambda immunoglobulin (IgL lambda). Recent studies describe the role of miR-650 in solid tumors, but its role in chronic lymphocytic leukemia (CLL) has not yet been studied. Our experiments demonstrate that miR-650 expression is regulated by coupled expression with its host gene for IgL lambda. This coupling provides a unique yet unobserved mechanism for microRNA gene regulation. We determine that higher expression of miR-650 is associated with a favorable CLL prognosis and influences the proliferation capacity of B cells. We also establish that in B cells, miR-650 targets proteins important in cell proliferation and survival: cyclin dependent kinase 1 (CDK1), inhibitor of growth 4 (ING4), and early B-cell factor 3 (EBF3). This study underscores the importance of miR-650 in CLL biology and normal B-cell physiology.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
NT11218, research and development projectName: Funkční a strukturní změny microRNA u lymfoproliferativních malignit a jejich vliv na prognózu onemocnění a predikci léčebné odpovědi
PrintDisplayed: 26/4/2024 06:01